Pinworm Treatment Suspension
NDC Package 69452-515-49

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Pinworm Treatment (pyrantel pamoate) suspension is ■ shake well before use■ read bottle label and package insert carefully before taking this medication■ treat the entire household unless otherwise advised. This formulation utilizes a suspension delivery system. Marketed by Bionpharma Inc., this product is identified by NDC 69452-515 and is authorized under FDA application M024.

Identification & Billing

NDC Package Code
69452-515-49
Package Description
1 BOTTLE in 1 CARTON / 30 mL in 1 BOTTLE
Product Code
69452-515
11-Digit Billing Format
69452051549
RxNorm Crosswalk
  • RxCUI: 199106 - pyrantel pamoate 144 MG in 1 mL Oral Suspension
  • RxCUI: 199106 - pyrantel pamoate 144 MG/ML Oral Suspension
  • RxCUI: 199106 - pyrantel pamoate 144 MG per 1 ML Oral Suspension
  • RxCUI: 199106 - pyrantel pamoate 144 MG/ML (pyrantel base 50 MG/ML) Oral Suspension

Clinical Specifications

Proprietary Name
Pinworm Treatment
Non-Proprietary Name
Pyrantel Pamoate
Substance Name
Pyrantel Pamoate
Dosage Form
Suspension - A liquid1 dosage form that contains solid particles dispersed in a liquid vehicle.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
PYRANTEL PAMOATE 144 mg/mL
Usage Information
■ shake well before use■ read bottle label and package insert carefully before taking this medication■ treat the entire household unless otherwise advised. See Warnings■ do not repeat treatment unless directed by a doctor■ this product can be taken any time of day, with or without meals. It may be taken alone or with milk or fruit juice. Use of a laxative is not necessary prior to, during or after medication■ if signs of pinworms persist after treatment, consult a doctorWeightDosage(taken as a single dose)Less than 25 lb. or under 2 yrs.oldDo not use unless directed by a doctor25-37 lb.1/2 teaspoonful38-62 lb.1 teaspoonful63-87 lb.1 1/2 teaspoonfuls88-112 lb.2 teaspoonfuls113-137 lb.2 1/2 teaspoonfuls138-162 lb.3 teaspoonfuls163-187 lb.3 1/2 teaspoonfuls188 lb. and over4 teaspoonfuls

Regulatory & Marketing

Labeler Name
Bionpharma Inc.
Product Type
Human Otc Drug
FDA Application #
M024
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
09-08-2025
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (69452-515). Click a package code to view its specific billing and regulatory data.

69452-515-38
2 BOTTLE in 1 CARTON / 30 mL in 1 BOTTLE (69452-515-36)
69452-515-88
473 mL in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69452-515-49 identifies a specific commercial package of 1 bottle in 1 carton / 30 ml in 1 bottle of Pinworm Treatment, a human over the counter drug labeled by Bionpharma Inc.. This suspension is formulated for oral use and contains pyrantel pamoate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bionpharma Inc. on September 08, 2025. The current certification is valid through December 31, 2027.

How is this Bionpharma Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69452051549. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
69452-515-49
11-Digit CMS (5-4-2)
69452-0515-49

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.